Relocation driven by increased demand for Vector Laboratories’ growing areas of focus, glycomics and proteomics Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today opened its new facility in Newark, California, where it will relocate its corporate headquarters this year. The relocation is accompanied by the rebranding and launch of a new corporate […]

Financing demonstrates the value of Laminar Wash technology in accelerating and standardizing therapeutic research and development WOBURN, Mass. — Curiox Biosystems, Inc., the global leader in biological sample preparation automation, announced today the completion of a $15 million (17.1 billion won) Series C financing round. Luha Private Equity led the deal, joined by other existing investors KB Investment Co., […]

Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces that it has been selected to provide tertiary analysis for whole genome sequencing services for the Hong Kong Genome Project (HKGP), the first large-scale genome sequencing initiative in Hong Kong. The HKGP, being […]

Gibco CTS Xenon Electroporation System complements Thermo Fisher Scientific’s portfolio of end-to-end cell therapy solutions CARLSBAD, Calif. – Thermo Fisher Scientific, the world leader in serving science, has introduced a new large-volume electroporation system that allows cell therapy developers to more easily move from clinical development to commercial manufacturing. The Gibco CTS Xenon Electroporation System leverages […]

Gibco CTS Xenon Electroporation System complements Thermo Fisher Scientific’s portfolio of end-to-end cell therapy solutions CARLSBAD, Calif. – Thermo Fisher Scientific, the world leader in serving science, has introduced a new large-volume electroporation system that allows cell therapy developers to more easily move from clinical development to commercial manufacturing. The Gibco CTS Xenon Electroporation System leverages […]

Partnership will expand use of next-generation sequencing (NGS) to help diagnose patients quickly and more accurately. NEW DELHI – Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) and Trivitron Healthcare, one of India’s largest medical technology companies, have entered into a strategic partnership to develop and expand the use of next-generation sequencing (NGS)-based in-vitro diagnostic tests (IVD) […]

Experienced Product and Operations Leader to Accelerate Delivery of Ambitious Roadmap in Single Cell Genomics SAN DIEGO, Calif. and CAMBRIDGE, UK — CS Genetics, a privately held genomics-technology company, today announced the appointment of Jay Harger, PhD, as Senior Vice President of Operations. Jay will lead a variety of critical company operations including facilities, manufacturing […]

 The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal the specific molecular profile […]

Hamburg — Eppendorf has made a strategic investment in BigOmics Analytics SA, a software company from Switzerland that develops digital cloud-based self-service tools to analyze molecular biology research data. “We’re excited to invest in BigOmics,” said Peter Fruhstorfer, Co-CEO of Eppendorf SE, upon signing the agreement. “With its expertise and digital know-how, the company is […]

San Diego, Calif. – Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health (NASDAQ: GTH), Tech Coast Angels, Ladder Ventures, and Hiaqua Investments were joined by existing investors Agilent Technologies (NYSE: A), Co-win Ventures, Vectr Ventures and Berkeley […]